Intravenous and intrapulmonary recombinant tissue-type plasminogen activator in the treatment of acute massive pulmonary embolism.
暂无分享,去创建一个
P. Mombaerts | G. Miller | M. Verstraete | H. Bounameaux | C. Olsson | H. Bounameaux | B. Charbonnier | J. Colle | G. Marbet | G. Lecorf | Gah Miller
[1] M. Mcnamara. Intravenous and intrapulmonary recombinant tissue-type plasminogen activator in the treatment of acute massive pulmonary embolism: Verstraete M, Miller GAH, Bounameaux H, et al. Circulation 1988;77:353-60 , 1989 .
[2] E. Braunwald,et al. ACUTE PULMONARY EMBOLISM TREATED WITH TISSUE PLASMINOGEN ACTIVATOR , 1986, The Lancet.
[3] E. Braunwald,et al. Intravenous recombinant tissue-type plasminogen activator in patients with acute myocardial infarction: a report from the NHLBI thrombolysis in myocardial infarction trial. , 1986, Circulation.
[4] D. Collen,et al. Assay of Human Tissue-Type Plasminogen Activator (t-PA) with an Enzyme-Linked Immunosorbent Assay (ELISA) Based on Three Murine Monoclonal Antibodies to t-PA , 1985, Thrombosis and Haemostasis.
[5] W. Ganz,et al. The thrombolysis in myocardial infarction (TIMI) trial. , 1985, The New England journal of medicine.
[6] T. Drake. Randomised trial of intravenous recombinant tissue-type plasminogen activator versus intravenous streptokinase in acute myocardial infarction , 1985 .
[7] B E Sobel,et al. Coronary thrombolysis with recombinant human tissue-type plasminogen activator: a prospective, randomized, placebo-controlled trial. , 1984, Circulation.
[8] P. Petitpretz,et al. Effects of a single bolus of urokinase in patients with life-threatening pulmonary emboli: a descriptive trial. , 1984, Circulation.
[9] B. Charbonnier. Etude multicentrique sur deux protocoles d'urokinase dans l'embolie pulmonaire grave , 1984 .
[10] A. Larcan,et al. Thrombolyse in situ des embolies pulmonaires graves et massives par urokinase avec ou sans plasminogène. A propos de 40 cas , 1983 .
[11] O. Matsuo,et al. Thrombolysis by human tissue plasminogen activator and urokinase in rabbits with experimental pulmonary embolus , 1981, Nature.
[12] A. Sasahara,et al. Effect of thrombolytic therapy on pulmonary-capillary blood volume in patients with pulmonary embolism. , 1980, The New England journal of medicine.
[13] H. Arnesen,et al. A controlled clinical trial of streptokinase and heparin in the treatment of major pulmonary embolism. , 2009, Acta medica Scandinavica.
[14] J. Anderson,et al. Comparison by Controlled Clinical Trial of Streptokinase and Heparin in Treatment of Life-threatening Pulmonary Embolism , 1974, British medical journal.
[15] M. Guest,et al. Hemodynamic effects of bolus infusion of urokinase in pulmonary thromboembolism. , 1974, The American review of respiratory disease.
[16] G. Sutton,et al. Comparison of Streptokinase and Heparin in Treatment of Isolated Acute Massive Pulmonary Embolism* , 1971, British heart journal.
[17] I. McDonald,et al. Streptokinase therapy in acute major pulmonary embolism. , 1970, American heart journal.
[18] P. Lalezari,et al. A Rapid, Simple, Sensitive Method for Measuring Fibrinolytic Split Products in Human Serum∗ , 1969, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.